Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval

Filament Health Announces Third Quarter 2024 Financial Results And Operational Highlights

Innovative trial will use psilocybin to target relapse in opioid addiction

Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement